Looking for better interest on the money you have piling up? You’re not alone! Read on to learn why October 2021 is likely the best month ever to buy U.S. Series I Savings bonds (I ...
Protagonist Therapeutics Inc. (PTGX) and TCR2 Therapeutics Inc. (TCRR) have plunged in the past week, after disappointing results of their respective clinical trials. The news has created bearish momentum for each stock that is unlikely ...
Corvus Pharmaceuticals (CRVS) is a medium-stage clinical biotechnology company that concentrates on developing novel immuno-oncology therapies. The company’s lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody that is being developed to treat HPV+ ...
You are now leaving a Magnifi Communities' website and are going to a website that is not operated by Magnifi Communities. This website is operated by Magnifi LLC, an SEC registered investment adviser affiliated with Magnifi Communities.
Magnifi Communities does not endorse this website, its sponsor, or any of the policies, activities, products, or services offered on the site. We are not responsible for the content or availability of linked site.